Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Ross

Showing results (641-650 of 670) with videos related to

Pageof 67
Sort By:
Progress in Retinal and Eye Research|October 12, 2025
Microbiome signatures and their role in uveitis: Pathogenesis, diagnostics, and therapeutic perspectivesKajal Agrawal, Ashley Shuen Ying Hong, Carlos Cifuentes-González, et al.
Brain, Behavior, and Immunity|December 19, 2022
Critical windows of early-life microbiota disruption on behaviour, neuroimmune function, and neurodevelopmentCaoimhe M K Lynch, Caitlin S M Cowan, Thomaz F S Bastiaanssen, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
<i>Eggerthella lenta</i> evades bacteriophage through reversible megabase-scale inversions of capsular polysaccharide gene clustersShenwei Zhang, Colin Buttimer, Kai R Trepka, et al.
Nutrients|August 27, 2021
Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot TrialChristiane Laue, Yala Stevens, Monique van Erp, et al.
Advances in Nutrition (Bethesda, Md.)|June 3, 2026
Probiotic human study design and reporting (PRODARE): recommendations to improve research practiceHania Szajewska, Marc Benninga, Georgia Chatonidi, et al.
The Lancet. Oncology|March 6, 2017
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, Daniel H Palmer, William Greenhalf, et al.
British Journal of Clinical Pharmacology|July 2, 2026
UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)Dharmisha Chauhan, Cinzia Dello Russo, Jack Thompson, et al.
Ebiomedicine|December 22, 2020
Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to humanHarriët Schellekens, Cristina Torres-Fuentes, Marcel van de Wouw, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2010
Composition, variability, and temporal stability of the intestinal microbiota of the elderlyMarcus J Claesson, Siobhán Cusack, Orla O'Sullivan, et al.
Nature Communications|February 24, 2026
Bifidobacterium longum and prebiotic interventions restore early-life high-fat/high-sugar diet-induced alterations in feeding behavior in adult miceCristina Cuesta-Marti, Eduardo Ponce-España, Friederike Uhlig, et al.
Pageof 67

Showing results (641-650 of 670) with videos related to

Sort By:
Pageof 67
Progress in Retinal and Eye Research|October 12, 2025
Microbiome signatures and their role in uveitis: Pathogenesis, diagnostics, and therapeutic perspectivesKajal Agrawal, Ashley Shuen Ying Hong, Carlos Cifuentes-González, et al.
Brain, Behavior, and Immunity|December 19, 2022
Critical windows of early-life microbiota disruption on behaviour, neuroimmune function, and neurodevelopmentCaoimhe M K Lynch, Caitlin S M Cowan, Thomaz F S Bastiaanssen, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
<i>Eggerthella lenta</i> evades bacteriophage through reversible megabase-scale inversions of capsular polysaccharide gene clustersShenwei Zhang, Colin Buttimer, Kai R Trepka, et al.
Nutrients|August 27, 2021
Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot TrialChristiane Laue, Yala Stevens, Monique van Erp, et al.
Advances in Nutrition (Bethesda, Md.)|June 3, 2026
Probiotic human study design and reporting (PRODARE): recommendations to improve research practiceHania Szajewska, Marc Benninga, Georgia Chatonidi, et al.
The Lancet. Oncology|March 6, 2017
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, Daniel H Palmer, William Greenhalf, et al.
British Journal of Clinical Pharmacology|July 2, 2026
UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)Dharmisha Chauhan, Cinzia Dello Russo, Jack Thompson, et al.
Ebiomedicine|December 22, 2020
Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to humanHarriët Schellekens, Cristina Torres-Fuentes, Marcel van de Wouw, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2010
Composition, variability, and temporal stability of the intestinal microbiota of the elderlyMarcus J Claesson, Siobhán Cusack, Orla O'Sullivan, et al.
Nature Communications|February 24, 2026
Bifidobacterium longum and prebiotic interventions restore early-life high-fat/high-sugar diet-induced alterations in feeding behavior in adult miceCristina Cuesta-Marti, Eduardo Ponce-España, Friederike Uhlig, et al.
Pageof 67